Display options
Cite
Kurosawa T, Yamada A, Takami M, et al. Expression of nephronectin is inhibited by oncostatin M via both JAK/STAT and MAPK pathways. FEBS Open Bio. 2015;5:303-7doi: 10.1016/j.fob.2015.04.001.
Kurosawa, T., Yamada, A., Takami, M., Suzuki, D., Saito, Y., Hiranuma, K., Enomoto, T., Morimura, N., Yamamoto, M., Iijima, T., Shirota, T., Itabe, H., & Kamijo, R. (2015). Expression of nephronectin is inhibited by oncostatin M via both JAK/STAT and MAPK pathways. FEBS open bio, 5303-7. https://doi.org/10.1016/j.fob.2015.04.001
Kurosawa, Tamaki, et al. "Expression of nephronectin is inhibited by oncostatin M via both JAK/STAT and MAPK pathways." FEBS open bio vol. 5 (2015): 303-7. doi: https://doi.org/10.1016/j.fob.2015.04.001
Kurosawa T, Yamada A, Takami M, Suzuki D, Saito Y, Hiranuma K, Enomoto T, Morimura N, Yamamoto M, Iijima T, Shirota T, Itabe H, Kamijo R. Expression of nephronectin is inhibited by oncostatin M via both JAK/STAT and MAPK pathways. FEBS Open Bio. 2015 Apr 08;5:303-7. doi: 10.1016/j.fob.2015.04.001. eCollection 2015. PMID: 25905035; PMCID: PMC4404411.
Copy Download .nbib Format: NLM
Share it on

FEBS Open Bio. 2015 Apr 08;5:303-7. doi: 10.1016/j.fob.2015.04.001. eCollection 2015.

Expression of nephronectin is inhibited by oncostatin M via both JAK/STAT and MAPK pathways.

FEBS open bio

Tamaki Kurosawa, Atsushi Yamada, Masamichi Takami, Dai Suzuki, Yoshiro Saito, Katsuhiro Hiranuma, Takuya Enomoto, Naoko Morimura, Matsuo Yamamoto, Takehiko Iijima, Tatsuo Shirota, Hiroyuki Itabe, Ryutaro Kamijo

Affiliations

  1. Department of Biochemistry, School of Dentistry, Showa University, Shinagawa, Tokyo 142-8555, Japan ; Division of Biological Chemistry, Department of Molecular Biology, Showa University School of Pharmacy, Shinagawa, Tokyo 142-8555, Japan.
  2. Department of Biochemistry, School of Dentistry, Showa University, Shinagawa, Tokyo 142-8555, Japan.
  3. Department of Pharmacology, School of Dentistry, Showa University, Ohta, Tokyo 145-8515, Japan.
  4. Department of Biochemistry, School of Dentistry, Showa University, Shinagawa, Tokyo 142-8555, Japan ; Department of Oral and Maxillofacial Surgery, School of Dentistry, Showa University, Ohta, Tokyo 145-8515, Japan.
  5. Department of Biochemistry, School of Dentistry, Showa University, Shinagawa, Tokyo 142-8555, Japan ; Department of Perioperative Medicine Division of Anesthesiology, School of Dentistry, Showa University, Ohta, Tokyo 145-8515, Japan.
  6. Department of Biochemistry, School of Dentistry, Showa University, Shinagawa, Tokyo 142-8555, Japan ; Department of Periodontology, School of Dentistry, Showa University, Ohta, Tokyo 145-8515, Japan.
  7. Brain Science Laboratory, The Research Organization of Science and Technology, Ritsumeikan University, Kusatsu, Shiga 525-8577, Japan.
  8. Department of Periodontology, School of Dentistry, Showa University, Ohta, Tokyo 145-8515, Japan.
  9. Department of Perioperative Medicine Division of Anesthesiology, School of Dentistry, Showa University, Ohta, Tokyo 145-8515, Japan.
  10. Department of Oral and Maxillofacial Surgery, School of Dentistry, Showa University, Ohta, Tokyo 145-8515, Japan.
  11. Division of Biological Chemistry, Department of Molecular Biology, Showa University School of Pharmacy, Shinagawa, Tokyo 142-8555, Japan.

PMID: 25905035 PMCID: PMC4404411 DOI: 10.1016/j.fob.2015.04.001

Abstract

Nephronectin (Npnt), also called POEM, is an extracellular matrix protein considered to play critical roles as an adhesion molecule in the development and functions of various tissues, such as the kidneys, liver, and bones. In the present study, we examined the molecular mechanism of Npnt gene expression and found that oncostatin M (OSM) strongly inhibited Npnt mRNA expression in MC3T3-E1 cells from a mouse osteoblastic cell line. OSM also induced a decrease in Npnt expression in both time- and dose-dependent manners via both the JAK/STAT and MAPK pathways. In addition, OSM-induced inhibition of osteoblast differentiation was recovered by over-expression of Npnt. These results suggest that OSM inhibits Npnt expression via the JAK/STAT and MAPK pathways, while down-regulation of Npnt by OSM influences inhibition of osteoblast differentiation.

Keywords: BMP-2, bone morphogenetic protein-2; ERK, extracellular signal-regulated kinase; JAK, janus kinase; JAK/STAT; JNK, c-Jun N-terminal kinase; MAM, meprin, A5 protein, and receptor protein-tyrosine phosphatase μ; MAPK; MAPK, mitogen-activated protein kinase; MEF2, myocyte enhancer-binding factor 2A; Nephronectin; Npnt, nephronectin; OSM, oncostatin M; OSMR, OSM receptor; Oncostatin M; STAT, signal transducer and activator of transcription; TGF-β, transforming growth factor-β; TNF-α, tumor necrosis factor-α

References

  1. J Bone Miner Res. 2004 Nov;19(11):1850-61 - PubMed
  2. FEBS Lett. 2007 Nov 13;581(27):5321-6 - PubMed
  3. J Immunol. 2001 Mar 1;166(5):3491-8 - PubMed
  4. Int Immunopharmacol. 2010 Jan;10(1):1-8 - PubMed
  5. Rev Physiol Biochem Pharmacol. 2003;149:39-52 - PubMed
  6. PLoS One. 2009 Oct 21;4(10):e7535 - PubMed
  7. Endocrinology. 1997 Sep;138(9):3666-76 - PubMed
  8. J Biol Chem. 2001 Nov 9;276(45):42172-81 - PubMed
  9. J Cell Biol. 2001 Jul 23;154(2):447-58 - PubMed
  10. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11458-63 - PubMed
  11. Development. 2007 Jul;134(13):2501-9 - PubMed
  12. Dev Cell. 2011 Feb 15;20(2):192-205 - PubMed
  13. Inflamm Res. 2011 Nov;60(11):1031-7 - PubMed
  14. Mol Cell Biol. 2005 Jul;25(14):5893-903 - PubMed
  15. FEBS Lett. 2010 Jul 2;584(13):2877-82 - PubMed
  16. Biochem Biophys Res Commun. 2011 Jul 15;410(4):766-70 - PubMed
  17. J Biol Chem. 1998 Aug 14;273(33):21137-44 - PubMed
  18. Cytokine. 2000 Oct;12 (10 ):1455-68 - PubMed
  19. FEBS Lett. 2010 Jan 4;584(1):233-8 - PubMed
  20. ISRN Inflamm. 2013 Dec 08;2013:512103 - PubMed
  21. Biochem Biophys Res Commun. 2013 Jan 11;430(2):751-6 - PubMed
  22. Zhonghua Yi Xue Za Zhi (Taipei). 1999 Oct;62(10):710-6 - PubMed
  23. Cell Res. 2011 Feb;21(2):350-64 - PubMed

Publication Types